„CIS Pharma is an innovator in the life science industry in the field of Oncology and Ophthalmolog. We were awarded with the European Frost & Sullivan Technology Innovation Award for our unique smart polymer technology“, says Christoph Schäfer, CEO of CIS Pharma.
“Our proprietary polymers are based on amino-acids exhibiting superior biocompatibility, resolving issues with conventional medical-grade polymers for bio-medical use. The polymers can be loaded with drugs for target-specific release, improving the quality of patient care and addressing unmet medical needs. With its intelligent functionally, the poylmers are finding strong prospects in various bio-medical applications.”
„The most noticeable factor is the control over chemical and physical properties“, explains Mukherjee of Frost and Sullivan. „With such intelligent functionality, the polymer platform opens a wide range of applications for drug delivery, bio-medical implants and replacements.“